For clinical deep sequencing process, construct the process with small amount input gDNA( ~ 50ng) and validate. To test, only human tumor cell lines were used.
There are 5 gDNA standard samples (including at least 2 bio-replicate data and diluted 3,6,12 times replicate data) to validate the feasibility of the SEGF method.